![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
It was to be a good read. From the email to the title, the messaging indicated the content offered valuable insights. She handed over her information. Now, she feels cheated. Why do brands produce content that lets...
Marketeer zoekt balans inzet off- en online media
Een groot deel van de marketeers wereldwijd (46%) geeft aan nog niet de juiste balans en synergie te hebben gevonden in de inzet van online en offline media. Zo worstelt driekwart (76%) nog steeds met het meten van...
Wat je voor 2020 moet weten over data-driven marketing [4 trends]
Data zijn de basis voor succesvolle marketingactiviteiten. En niet alleen bij corporates, maar ook in het MKB en de grootzakelijke markt. Ik zet 4 trends rondom data-driven marketing voor je op een rij waarvan ik denk...
Roche’s Phase 3 Pemphix trial smashes primary endpoint for pemphigus vulgaris
Roche has revealed new Phase 3 data demonstrating that its MabThera/Rituxan (rituximab) therapy Pemphix met its primary endpoint in the treatment of moderate to severe pemphigus vulgaris (PV) in adult patients. The...
Advancements in the use of AI in Oncology explored at Cleveland
Artificial Intelligence, machine learning and smart computing are all rapidly transforming the global health and medical landscape, including at Case Western Reserve University and among its health-care partners in...
FDA Grants Fast Track Status to FX-322 for Sensorineural Hearing Loss
The Food and Drug Administration (FDA) has granted Fast Track designation to FX-322 (Frequency Therapeutics) for the treatment of sensorineural hearing loss. FX-322 is a combination of proprietary small molecules...
FDA approves Eli Lilly’s Reyvow for treatment of migraine in adults
The US FDA has approved Eli Lily’s oral therapy Reyvow (lasmiditan) for the acute treatment of adults with migraine with or without aura, with Lilly noting that this is ‘the first and only FDA-approved medicine in a new...
FDA approves Pfenex’s osteoarthritis drug for patients at high risk of fracture
The FDA has awarded US approval to Pfenex’s drug PF708, it has emerged, as a treatment for osteoporosis in certain patients at high risk for fracture, just like its reference product, Eli Lilly’s Forteo (teriparatide...
US FDA approves Novartis’ Beovu for wet age─related macular degeneration treatment
Novartis, a leading global medicines company, announced that the US Food and Drug Administration (FDA) approved Beovu (brolucizumab) injection, also known as RTH258 for the treatment of wet age─related macular...
Aethlon Medical gets US FDA nod to initiate early feasibility study of Hemopurifier in patients with head & neck cancer in combo Keytruda
Aethlon Medical, a therapeutic medical device and technology company focused on unmet needs in global health, announced that the US FDA has approved its Investigational Device Exemption (IDE) application to initiate an...
US FDA approves Clinuvel Pharma’s Scenesse for increase pain─free light exposure in patients with rare disorder
The US Food and Drug Administration (FDA) granted marketing approval to Clinuvel Pharma’s Scenesse (afamelanotide) to increase pain─free light exposure in adult patients with a history of phototoxic reactions...
US FDA approves Galderma’s Aklief cream to treat acne
Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced, that the US Food and Drug Administration (FDA) approved Aklief (trifarotene) cream, 0.005% for the topical
FDA approves Novartis’ Beovu injection for wet age-related macular degeneration
Novartis has secured FDA approval for its Beovu (brolucizumab) injection in the treatment of wet age-related macular degeneration (AMD), it has emerged. The decision makes it the first anti-VEGF drug approved by the FDA...
Hoe introduceer je een contentkalender in je organisatie? [Q&A]
Met veel mensen tegelijkertijd aan je content(strategie) werken, dat kan onoverzichtelijk worden. Hoe introduceer je een contentkalender? En hoe krijg je je collega’s zo ver dat ze ermee gaan werken? In deze...
How to Adopt a Growth Mindset for Your Content Marketing
Growth teams often include content creation and promotion in their actions. But how can content teams integrate the growth mindset in their daily routine? Here’s how to create a content idea pipeline. Continue reading →...
Boehringer Ingelheim’s phase III INBUILD trial of nintedanib in patients across a range of progressive fibrosing interstitial lung diseases meets primary endpoint
Boehringer Ingelheim, a research─driven pharmaceutical company, announced that in the phase III INBUILD trial nintedanib slowed lung function decline by 57% across the overall study population, as assessed
Novartis’ Cosentyx scores again in phase 3, strengthens approval claim
Scopes approval in non-radiographic axial spondyloarthritis
Diabetes drug could halt progression of multiple sclerosis, study suggests
Clinical trial in MS patients is planned following successful animal tests
